DUBLIN–(BUSINESS WIRE)–The “Anesthetics Global Market Report 2022, Type, Application, Route of Administration, Local Anesthetics, General Anesthetics” report has been added to ResearchAndMarkets.com’s offering.
The global anesthetics market is expected to grow from $9.24 billion in 2021 to $9.88 billion in 2022 at a compound annual growth rate (CAGR) of 7.0 %. The market is expected to reach $12.24 billion in 2026 at a CAGR of 5.5%.
Major players in the anesthetics market are Baxter, Abbott Laboratories, AstraZeneca, F. Hoffmann-La Roche AG, B. Braun Melsungen AG, AbbVie Inc., Hospira, Aspen, Boehringer Ingelheim International GmbH and Eisai Co. Ltd.
The anesthetics market consists of sales of drugs that cause a relaxing sensation to calm patients during surgery and remove the sensation of pain. These drugs are used to give a sense of calm to patients through muscle relaxation which also causes amnesia. The anesthetics market is divided into general anesthetics, regional anesthetics, and local anesthetics.
The main types of anesthetics are general anesthetics and local anesthetics. A medically induced coma with lack of defensive reflexes is known as general anaesthesia. It is caused by the injection of one or more general anaesthetic drugs. The different routes of administrations include Inhalation Anaesthesia Drugs, Intravenous Anaesthesia Drugs, Topical Anaesthesia Drugs and is used in various applications such as General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, Other Applications.
North America is the largest region in the anesthetics market in 2021. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The increase in the number of surgeries is one of the major drivers of the anesthetics market due to the applications of anesthetic drugs during surgical procedures. This rise is mainly due to increasing incidents of injuries and accidents that require surgeries. For example, according to WHO’s Global status report on road safety, the number of road accidents reached 1.35 million, with approximately 64 deaths for every 100,000 vehicles.
Stringent guidelines and regulations imposed by regulatory bodies are one of the important restraints for the anesthetics market. These guidelines include conducting clinical trials of newly developed drugs, standards related to patient safety, and monitoring of patients under anesthesia.
Complying with these guidelines and getting regulatory approvals consumes a lot of time and negatively impacts the growth of the anesthetics market. For example, the American Society of Anesthesiologists imposes various standards that apply to anesthesia care and monitoring of patients including standards for pre-, basic- and post-anesthesia care and monitoring.
Increasing consolidation in the form of acquisitions is an emerging trend in the anesthetics market. This is mainly due to the high level of R&D and intellectual property (IP) investment needed to establish companies that manufacture anesthetic drugs. In this regard, mergers and acquisitions are considered as time and cost-effective methods.
Some of the notable acquisitions in recent years include the acquisition of MyoScience by Pacira for $220 million in 2019, acquisition of Claris Injectables by Baxter for $625 million, acquisition of GSK’s anesthetics portfolio by Aspen for $238.7 million, and acquisition of Hospira by Pfizer for $17 billion.
Key Topics Covered:
1. Executive Summary
2. Anesthetics Market Characteristics
3. Anesthetics Market Trends And Strategies
4. Impact Of COVID-19 On Anesthetics
5. Anesthetics Market Size And Growth
5.1. Global Anesthetics Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Anesthetics Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Anesthetics Market Segmentation
6.1. Global Anesthetics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- General Anesthetics
- Local Anesthetics
6.2. Global Anesthetics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- General Surgeries
- Plastic Surgery
- Cosmetic Surgeries
- Dental Surgeries
- Other Applications
6.3. Global Anesthetics Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Inhalation Anaesthesia Drugs
- Intravenous Anaesthesia Drugs
- Topical Anaesthesia Drugs
6.4. Global Anesthetics Market, Segmentation By Local Anesthetics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Bupivacaine
- Ropivacaine
- Lidocaine
- Chloroprocaine
- Articaine
- Benzocaine
- Other Local Anesthesia Drugs
6.5. Global Anesthetics Market, Segmentation By General Anesthetics, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Propofol
- Sevoflurane
- Desflurane
- Dexmedetomidine
- Remifentanil
- Midazolam
- Other General Anesthesia Drugs
7. Anesthetics Market Regional And Country Analysis
7.1. Global Anesthetics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Anesthetics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Companies Mentioned
- Baxter
- Abbott Laboratories
- AstraZeneca
- F.Hoffmann-La Roche AG
- B. Braun Melsungen AG
- AbbVie Inc.
- Hospira
- Aspen
- Boehringer Ingelheim International GmbH
- Eisai Co. Ltd.
- Fresenius SE & Co. KGaA
- Hikma Pharmaceuticals PLC.
- PAION AG
- Pfizer
- Hameln Pharmaceuticals
- Maruishi Pharmaceuticals
- Pacira Pharmaceuticals Inc.
- Piramal Group
- Novartis International AG
- MYLAN NV
For more information about this report visit https://www.researchandmarkets.com/r/88frgz
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
